Overview

Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets

Status:
Completed
Trial end date:
2008-10-06
Target enrollment:
Participant gender:
Summary
This was an open-label, balanced, two-treatment, two-period, randomized sequence crossover bioequivalence study with a 7-day washout between periods. Each treatment was administered after an overnight (10 hours) fast.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
MonoSol Rx
Par Pharmaceutical, Inc.
Treatments:
Ondansetron